Bioregulator$35–$60

Pinealon: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 9 sources cited

Overview

Pinealon is a tripeptide bioregulator (Glu-Asp-Arg) developed by the Khavinson laboratory that was derived from the brain-cortex extract Cortexin and is studied for effects on central nervous system neurons; despite the name, no published study shows an effect on the pineal gland. It is designed to normalize neuronal function, and provide neuroprotection in aging brain tissue; the sleep and melatonin effects often claimed for it have not been tested in any published study. As a bioregulator, it is proposed to work through epigenetic modulation of gene expression.

Mechanism of Action

In cell studies, fluorescently labeled Pinealon entered cells and their nuclei and bound DNA in vitro; it is proposed to modulate gene expression related to neurotransmitter synthesis and antioxidant defense. Whether it crosses the blood-brain barrier has not been measured. It stimulated serotonin expression in aging cultures of brain cortex cells; effects on melatonin synthesis or circadian rhythm have not been shown. Additionally, Pinealon lowered reactive oxygen species in cultured rat cerebellar neurons and is reported to promote antioxidant enzyme synthesis there, which is the basis for the idea that it limits oxidative damage in the aging brain. It also modulates glutamate signaling, potentially providing neuroprotection against excitotoxicity.

Pinealon Benefits: What the Research Shows

  • In rat pineal gland cultures, Pinealon (Glu-Asp-Arg) did not stimulate the proliferation or secretory markers that Epitalon did (Bulletin of Experimental Biology and Medicine, 2011); no published study shows it changing melatonin production
  • Studies in Bulletin of Experimental Biology and Medicine showed the Glu-Asp-Arg tripeptide regulated gene expression in brain tissue cultures
  • Small Russian studies of oral Pinealon report improved memory and fewer headaches in 72 patients with after-effects of traumatic brain injury, and better biological-age indicators in 32 patients aged 41–83; none measured sleep
  • Preclinical studies demonstrated neuroprotective effects against oxidative stress-induced neuronal damage

Pinealon Dosage

  • Oral: 10–20 mg daily in capsule form for 10–30 days
  • Repeat cycles every 3–6 months
  • Best taken in the evening to align with melatonin production cycles
  • For sleep support: 10–20 mg 1–2 hours before bed
  • For neuroprotection: 20 mg daily for 20–30 days, cycled every 4–6 months
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Pinealon Side Effects & Safety

Known Side Effects

  • Drowsiness — reported by some users with evening dosing; a melatonin-stimulating effect has not been shown in studies
  • Vivid dreams — reported by some users; no study links this to pineal gland or melatonin activity
  • Mild GI discomfort — infrequently reported with oral dosing
  • Published human studies are small and did not systematically record adverse effects; one study of 32 patients noted pro-oxidant activity and a fall in circulating CD34+ blood stem cell markers

Safety Profile

Pinealon's safety has not been formally studied. No toxicology or pharmacokinetic studies are indexed in PubMed, and the few small human studies did not systematically record adverse events. None reported serious ones, but one noted pro-oxidant activity and lower circulating CD34+ cell markers. Long-term human clinical trial data is limited, with most evidence from Russian observational studies and preclinical research. Tolerability in the cyclic dosing patterns used has not been systematically reported, and drug interactions have not been studied.

What to Expect

Days 1–5: Users often describe falling asleep faster and better subjective sleep as the first effects, though no published study has measured sleep with Pinealon. More vivid dreams may occur. Days 5–15: Sleep becomes more restful and restorative. Users report feeling more refreshed upon waking. Daytime cognitive clarity may improve as sleep quality normalizes. Days 15–30: Gene expression effects have been shown only in cell cultures and animals. Users report sustained improvements in sleep, mood, and cognitive function. Post-cycle: How long any benefit lasts after a cycle has not been studied.

Common Stacks

Storage & Handling

Store Pinealon capsules at room temperature (15–25°C) in a dry place away from direct sunlight. Shelf life is typically 2–3 years for encapsulated bioregulators. No refrigeration needed for oral capsule form.

Pricing & Available Variants

$35 – $60price range
10mg20mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Khavinson V, Linkova N, Kozhevnikova E, et al. EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease. Molecules. 2020.
  2. Khavinson V, Ribakova Y, Kulebiakin K, et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Res. 2011.
  3. Arutjunyan A, Kozina L, Stvolinskiy S, et al. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. Int J Clin Exp Med. 2012.
  4. Khavinson V, Ilina A, Kraskovskaya N, et al. Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease. Pharmaceuticals (Basel). 2021.
  5. Khavinson VKh, Lin'kova NS, Tarnovskaya SI, et al. Short peptides stimulate serotonin expression in cells of brain cortex. Bull Exp Biol Med. 2014.
  6. Khavinson VKh, Linkova NS, Chalisova NI, et al. Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture. Bull Exp Biol Med. 2011.
  7. Meshchaninov VN, Tkachenko EL, Zharkov SV, et al. EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION. Adv Gerontol. 2015.
  8. Fedoreyeva LI, Kireev II, Khavinson VKh, et al. Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA. Biochemistry (Mosc). 2011.
  9. Kozina LS. Investigation of antihypoxic properties of short peptides. Adv Gerontol. 2008.

Related Peptides

Track Pinealon in Your Protocol

Log your Pinealon doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free